Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056598 · ClinicalTrials.gov registry record
Acne Vulgaris Related Microbiology and Serology
A clinical trial, sponsored by Sanofi.
- Completed
- Registry status
- 120
- Enrollment target
NCT04056598 is a clinical trial that has completed, run by Sanofi. The registered enrollment target is 120 participants.
The verdict
NCT04056598 has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
This will be an investigation to determine the quality of the serological immune responses against Propionibacterium acnes (P. acnes) in acne patients compared to healthy individuals. In particular, the investigators will measure serum antibody titers against P. acnes surface antigens, and the efficiency of antibody-mediated phagocytic killing of P. acnes.
Interventions
- DIAGNOSTIC_TEST Study of humoral immunity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2018-01-18 |
| Est. Completion | 2019-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04056598
The ClinicalTrials.gov registry entry for NCT04056598 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Study of humoral immunity is the first listed.
NCT04056598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04056598 about?
NCT04056598 is a clinical study titled "Acne Vulgaris Related Microbiology and Serology". This will be an investigation to determine the quality of the serological immune responses against Propionibacterium acnes (P. acnes) in acne patients compared to healthy individuals. In particular, the investigators will measure serum antibody titers against P. acnes surface antigens, and the effic...
What is the current status of trial NCT04056598?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2018-01-18. Estimated completion is 2019-09-30.
What interventions are being tested in trial NCT04056598?
The interventions under investigation include: Study of humoral immunity (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04056598?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.